Streamline Health reports Q1 EPS (40c) vs. (71c) last year
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 16 2025
0mins
Should l Buy ?
Q1 Revenue Performance: The company reported a Q1 revenue of $4.81 million, an increase from $4.33 million in the previous year.
Cash Position Update: As of April 30, cash and cash equivalents were $1.4 million, down from $2.2 million as of January 31.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
